DENTSPLY International Inc.  

(Public, NASDAQ:XRAY)   Watch this stock  
-0.03 (-0.06%)
Real-time:   1:31PM EST
NASDAQ real-time data - Disclaimer
Currency in USD
Range 50.24 - 50.92
52 week 42.99 - 56.25
Open 50.70
Vol / Avg. 339,897.00/936,547.00
Mkt cap 7.25B
P/E 23.51
Div/yield 0.07/0.52
EPS 2.16
Shares 141.53M
Beta 1.32
Inst. own 93%
Feb 16, 2015
Q4 2014 DENTSPLY International Inc Earnings Release (Estimated) - 12:01AM EST - Add to calendar
Jan 13, 2015
DENTSPLY International Inc at JPMorgan Healthcare Conference
Dec 2, 2014
DENTSPLY International Inc at NASDAQ OMX Investor Program
Nov 11, 2014
DENTSPLY International Inc at Credit Suisse Healthcare Conference
Oct 29, 2014
Q3 2014 DENTSPLY International Inc Earnings Release
Oct 29, 2014
Q3 2014 DENTSPLY International Inc Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 10.76% 10.75%
Operating margin 15.47% 14.21%
EBITD margin - 19.19%
Return on average assets 6.14% 6.31%
Return on average equity 11.89% 13.20%
Employees 11,800 -
CDP Score - -


Susquehanna Commerce Center 221 W. Philadelphia Street
YORK, PA 17405
United States - Map
+1-717-8457511 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Dentsply International Inc. is a designer, developer, manufacturer and marketer of consumable dental products for the professional dental market. The Company manufactures and markets other consumable medical device products. The Company�s product categories are dental consumable products, dental laboratory products, dental specialty products and consumable medical device products. The Company�s dental consumable products consist of value added dental supplies and devices and small equipment used in dental offices for the treatment of patients. The Company�s dental laboratory products are used in the preparation of dental appliances by dental laboratories. The Company�s dental specialty products are specialized treatment products used within the dental office and laboratory settings. The Company�s consumable medical device products consist mainly of urological products.

Officers and directors

Bret W. Wise Chairman of the Board, Chief Executive Officer
Age: 53
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Christopher T. Clark President, Chief Financial Officer
Age: 52
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
James G. Mosch Chief Operating Officer, Executive Vice President
Age: 56
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Robert J. Size Senior Vice President
Age: 55
Bio & Compensation  - Reuters
Albert J. Sterkenburg DDS Senior Vice President
Age: 50
Bio & Compensation  - Reuters
Deborah M. Rasin Vice President, General Counsel, Secretary
Age: 47
Bio & Compensation  - Reuters
William F. Hecht Lead Independent Director
Age: 77
Bio & Compensation  - Reuters
Michael C. Alfano Ph.D. Independent Director
Age: 65
Bio & Compensation  - Reuters
Eric K. Brandt Independent Director
Age: 52
Bio & Compensation  - Reuters
Paula H. J. Cholmondeley Independent Director
Age: 66
Bio & Compensation  - Reuters